About Molecular Vista
Molecular Vista is a Healthcare company based in San Jose (United States) founded in 2011 by Kumar Wickramasinghe and Sung Park. Manufacturer of photo-induced force microscopic (PiFM) systems. It operates in the Healthcare, Technology, and Industrial Goods & Manufacturing sectors. Molecular Vista has raised $660 thousand across 5 funding rounds from investors including Park Systems, OSTI.GOV and America’s Seed Fund. The company has 890 employees. Its chief executive, as recorded, is Sung Park. Its Indian entity Ta Associates Advisory Private Limited reported revenue of ₹183 Cr. Molecular Vista offers products and services including Vista 300, Vista 200, Vista 75, Vista One, and Contract Analysis Services. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Imaging Systems.
Company details
Molecular Vista was founded in 2011 and is headquartered in San Jose, United States. Photo-induced force microscopic (PiFM) systems are manufactured for applications in chemical analysis. Photo-induced force microscopy and photo-induced force infrared spectroscopy solutions are developed to enable nanometer-scale resolution. A hybrid atomic force microscopy (AFM) and optical spectroscopy platform is offered for examining material and biological systems with chemical specificity in the scientific instruments sector.
- Headquarters San Jose, United States
- Employees 890
- Founders Kumar Wickramasinghe, Sung Park
- SectorsHealthcareTechnology Industrial Goods & Manufacturing
- Email••••••••
- Phone•••• ••••
- Website molecularvista.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Molecular Vista, Inc.
- Date of Incorporation 15 Dec, 2008
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹183 Cr
FY 2026 · -11% YoY
- Indian entity net profit₹22.44 Cr
FY 2026 · 12% margin
- Indian entity EBITDA₹31.80 Cr
FY 2026 · 17% margin
- Total Equity Funding$660K (USD)
in 5 rounds
- InvestorsPark Systems
& 2 more
- Employee Count890
Associated legal entities of Molecular Vista
Molecular Vista operates through Ta Associates Advisory Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ta Associates Advisory Private Limited CIN U74900MH2008PTC188893 | Active | 15 Dec 2008 | Mumbai, Maharashtra | ₹183 Cr | 3 | View details |
Products & Services of Molecular Vista
Molecular Vista offers a comprehensive portfolio of products and services, including Vista 300, Vista 200, Vista 75, Vista One, and Contract Analysis Services.
Advanced system with automated features for nanoscale chemical analysis
Instrument for fast nano-scale material analysis
High-resolution tool for chemical imaging
System for nanoscale IR spectroscopy applications
Expert service for nanoscale chemical information
Apps and channels of Molecular Vista
its YouTube channel Molecular Vista has 115 subscribers and 15 videos.
Videos from Molecular Vista
The most watched videos on Molecular Vista's YouTube channel, Molecular Vista (115 subscribers). Click a video to play it here.
More on Molecular Vista.
Funding Insights of Molecular Vista
Molecular Vista has successfully raised a total of $660K across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $660,000
- Total Rounds 5
- First Round $660,000
(Feb 2012)
- Investors Count 3
All 5 funding rounds of Molecular Vista with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2020 | Seed | – | Park Systems | – | |
| Feb 2015 | $1.24M | Grant | – | – | |
| Apr 2014 | $1.41M | Grant | – | – | |
| Jan 2013 | $179,998 | Grant | – | – | |
| Feb 2012 | $660,000 | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in Molecular Vista
Molecular Vista has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Park Systems, OSTI.GOV and America’s Seed Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States | ||
Scanning probe microscopes are manufactured for nanoimaging applications. | 1997 | parksystems.com | Suwon-si, South Korea | |
Scientific and technical information is managed and disseminated by OSTI.GOV. | osti.gov | Oak Ridge, United States |
Investor details for Molecular Vista
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ta Associates Advisory Private Limited (Molecular Vista)
Ta Associates Advisory Private Limited is the primary company behind Molecular Vista. The board of Ta Associates Advisory Private Limited currently have 3 directors; the longest-serving is Melanie Rae Toomey, appointed in 2015. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Melanie Rae Toomey DIN 07103302 | Director | 02 Mar 2015 | 11 yrs 8 mo | Ta Associates Advisory Private Limited |
| Ravindranath Menon Kizhakkepat Bhaskaran DIN 02579565 | Director | 01 Feb 2021 | 5 yrs 9 mo | Ta Associates Advisory Private Limited |
| Jennifer Ami Barbetta DIN 10709061 | Director | 25 Jul 2024 | 2 yrs 3 mo | Ta Associates Advisory Private Limited |
People of Molecular Vista
7 people are tracked at Molecular Vista (4 in leadership, 3 in team); the tracked headcount is 890.
| Name | Role | Group |
|---|---|---|
Kumar Wickramasinghe | Co-Founder | Leadership |
Sung Park | Co-Founder & CEO | Leadership |
Thomas Albrecht | VP Of Engineering And Product Development | Leadership |
Samuel S. Byun | Head Of Product & Sales | Leadership |
Christine Albrecht | Applications Scientist | Team |
Graceson Aufderheide | Application Engineer | Team |
Gay Nelson | Office Manager/accountant | Team |
Complete people profiles for Molecular Vista
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Molecular Vista
Figures of Ta Associates Advisory Private Limited, the primary company behind Molecular Vista, for FY 2026. Revenue was ₹183 Cr (-11% year on year). Net profit was ₹22.44 Cr (12% margin). EBITDA was ₹31.80 Cr (17% margin). Revenue has grown at a compounded annual rate of +18% over three years and +25% over five years.
- ₹183 CrRevenue · FY 2026 · -11% YoY
- ₹22.44 CrNet profit · 12% margin
- ₹31.80 CrEBITDA · 17% margin
- ₹2.56 CrPaid-up capital
- +18%Revenue CAGR, 3 years
- +25%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ta Associates Advisory Private Limited are on its company page.
Detailed financial statements for Molecular Vista
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Molecular Vista
3 dated milestones of Molecular Vista across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Molecular Vista is founded.
- Funding First funding round of $660K.
- Funding Latest funding round, Seed,.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Molecular Vista (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Molecular Vista
Complete news archive for Molecular Vista
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Vista
Molecular Vista was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Molecular Vista is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Sung Park is the CEO of Molecular Vista, as recorded in our data. They have also founded this company.
Molecular Vista is a funded company, having raised a total of $660K across 5 funding rounds to date. The company's 1st funding round was a Seed of $660K, raised on Feb 2012.
Molecular Vista has 890 employees.
The primary company behind Molecular Vista, Ta Associates Advisory Private Limited, reported revenue of ₹183 Cr for FY 2026, down 11% year on year.
Molecular Vista was founded in 2011 and is headquartered in San Jose, United States. Photo-induced force microscopic (PiFM) systems are manufactured for applications in chemical analysis. Photo-induced force microscopy and photo-induced force infrared spectroscopy solutions are developed to enable nanometer-scale resolution. A hybrid atomic force microscopy (AFM) and optical spectroscopy platform is offered for examining material and biological systems with chemical specificity in the scientific instruments sector.
Molecular Vista offers Vista 300, Vista 200, Vista 75, Vista One, and Contract Analysis Services.
Molecular Vista has 3 investors. Key investors include Park Systems, OSTI.GOV, and America’s Seed Fund.
Molecular Vista operates through Ta Associates Advisory Private Limited.
The legal entities of Molecular Vista currently have 3 directors, including Melanie Rae Toomey, Ravindranath Menon Kizhakkepat Bhaskaran, Jennifer Ami Barbetta.